Together in the same boat, unity, overcoming difficulties
Release time:
2021-02-10
Together in the same boat, uniting to overcome difficulties
Group Company's 2020 advanced enterprise Yunnan Jianfeng Cement Company
2020 was an extraordinary year. At the beginning of the New Year, a sudden outbreak of new crown pneumonia swept across the world, which had a significant impact on the world economy, security and global development trend, as well as on the development trend of the regional economy. Yunnan peak all employees in the same boat, unity, overcome difficulties, overcome the impact of the epidemic and regional new production capacity, against the trend to create the highest sales in the eight years since the establishment of the plant, become the only sales in southwest Yunnan region exceeded last year, the only receivables cleared of the same industry enterprises, successfully completed the task assigned by the group. It is not easy to achieve such achievements. In the past year, the team combat effectiveness of Yunnan Jianfeng has not weakened, and all work has been carried out in an orderly manner. This is the result of the unity and hard work of the whole company.
In last year's work, we faced unfavorable factors such as large fluctuations in the cement market and low-cost market placement of new production capacity in the region. We dig deep into the market potential, seize key projects, through a variety of flexible policy stimulus, increase the end market run and investment and other measures, to maintain the southwest region of single-line cement sales of enterprises, effectively improve the peak brand cement sales and market share. Internally, management work is always put at the center to achieve benefits through management and promote development through management; adhere to the combination of institutionalized management and humanized management, division of labor and cooperation, and close cooperation; let employees fully display their talents in their respective posts, and show their dedication and lofty quality of dedication with practical actions and remarkable work achievements; through continuous and in-depth development of "three reductions and three improvements", optimize resource allocation, and strengthen target responsibility system management; improve the quality and progress of various tasks, and relatively reduce process, equipment, and quality failures in the production process; while advancing various technologies in an orderly manner While reforming the project, through the sorting and improvement of equipment inspection related systems and the training of equipment inspection skills, the skill level of employees is further improved, and the company's equipment management mode is standardized, improve the effective operation rate of equipment.
Yunnan Jianfeng Party Working Group closely focuses on the work of the enterprise center, carries out various activities that help to enhance the corporate image, enhance the sense of belonging and responsibility of employees, and create a good atmosphere for the healthy and orderly development of the enterprise. During the epidemic period, the company strictly implemented epidemic prevention measures, focusing on epidemic prevention on the one hand and production on the other, uniting and leading cadres and employees to implement various tasks. While production and operation reached a record high, no one in the factory was infected.
achievements can only represent the past, glory lies in our continued efforts. In the work in 2021, all our employees will closely focus on the group's various work arrangements, irrigate hope with sweat, and move forward with hard work. Meet the challenge attentively, devote yourself to the heat wave of work with a new look and a hundred times of enthusiasm, contribute to the development of the peak and create value. (According to the speech made by Zhou Jiping, former general manager of Yunnan Jianfeng Cement Company, at the commendation meeting of the group company)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31